Last month, in Qualcomm Inc. v. Intel Corp., the Court of Appeals for the Federal Circuit (“the CAFC”) vacated and remanded the Patent Trial and Appeal Board (“the Board”) on six inter partes review (“IPR”) decisions that held claims 1-15,
The PTAB Law Blog, published by Rothwell Figg, focuses on developments and analysis related to the Patent Trial and Appeal Board (PTAB) proceedings, including inter partes review (IPR), post grant review (PGR), and other patent post-grant challenges. It covers procedural changes, discretionary denial policies, claim construction issues, and Federal Circuit decisions impacting PTAB practice. The blog discusses strategic considerations for patent practitioners, updates on USPTO policies, and case law interpretations relevant to patent litigation and administrative patent trials. It serves as a resource for understanding the evolving landscape of patent trial practice before the PTAB and related appellate decisions.
On April 15, 2021, the United States Patent and Trademark Office (“USPTO”) implemented the COVID-19 Prioritized Examination Pilot Program (“Pilot Program”) to fast-track ex parte appeals of products or processes subject to an applicable FDA approval for COVID-19 use.
Generally,…